Report Summary 1. Report Industry Investment Rating No information provided in the content. 2. Core Viewpoints of the Report - This week, the average prices of pure MDI, polymerized MDI, and TDI in the polyurethane industry were 17,843 yuan/ton, 14,014 yuan/ton, and 14,188 yuan/ton respectively, with week - on - week decreases of 200 yuan/ton, 157 yuan/ton, and 290 yuan/ton. Their respective gross profits also declined [2]. - In the oil - gas - olefin sector, prices of raw materials such as ethane, propane, etc. had different changes this week. The average prices of polyethylene and polypropylene increased, and the theoretical profits of different production routes also changed accordingly [2]. - In the coal - chemical industry, the average prices of synthetic ammonia, urea, DMF, and acetic acid had slight fluctuations, and their gross profits also changed slightly [2]. - In the animal nutrition products sector, the average prices of VA, VE, solid methionine, and liquid methionine had minor changes this week [2]. 3. Summary by Relevant Catalogs 1. Basic Chemical Weekly Data Briefing - **Related Company Performance Tracking** - The Basic Chemical Index had a weekly increase of 0.9%, a monthly increase of 12.3%, a quarterly increase of 12.9%, an annual increase of 44.7%, and a year - to - date increase of 6.0% as of 2026/1/16. Different chemical companies had different performance in terms of stock price changes and earnings. For example, Wanhua Chemical's stock price decreased by 0.8% this week, while Baofeng Energy's increased by 5.2% [8]. - The report also provided data on the total market value, net profit attributable to the parent company, PE, and PB of relevant companies from 2024A to 2027E [8]. - **Industry Chain Data** - **Polyurethane Industry Chain**: The average prices and gross profits of pure MDI, polymerized MDI, and TDI decreased this week. Their respective seven - year quantiles were 51%, 45%, and 65% for prices, and 71%, 49%, and 71% for gross profits [8]. - **Oil - Gas - Olefin Industry Chain**: - **Raw Material Prices**: The average prices of ethane, propane, NYMEX natural gas, Brent crude oil, and naphtha had different changes. Their ten - year quantiles also varied [8]. - **Profit Comparison of Different Routes**: The single - ton profits of different production routes for polyethylene and polypropylene had different changes compared to the previous week, the beginning of the year, and the same period last year [8]. - **C2 and C3 Plates**: The average prices and price differences between products and raw materials in the C2 and C3 plates had different changes, with different ten - year quantiles. For example, the price of ethylene decreased by 90 yuan/ton, and the price difference between HDPE and ethylene increased by 353 yuan/ton [10]. - **Coal - Chemical Industry Chain**: - **Coal - Coke Products**: The average prices of coking coal and coke decreased, and the gross profit of coke was - 47 yuan/ton, with a 3 - yuan decrease [10]. - **Traditional Coal - Chemical Products**: The average prices and gross profits of synthetic ammonia, methanol, urea, DMF, and acetic acid had different changes, with different seven - year quantiles [10]. - **New Materials**: The average prices and gross profits of DMC, oxalic acid, octanol, adipic acid, caprolactam, PA6, and PA66 had different changes, with different seven - year quantiles [10]. - **Animal Nutrition Products Industry Chain**: The average prices of VA, VE, solid methionine, and liquid methionine changed slightly, with different ten - year quantiles [10]. 2. Basic Chemical Weekly Report - **2.1 Basic Chemical Index Trends**: The report did not provide specific content in the text, only the title. - **2.2 Polyurethane Sector**: The report presented the price trends of pure MDI, polymerized MDI, and TDI in China, as well as their price - spread situations [16][18][20]. - **2.3 Oil - Gas - Olefin Sector**: It showed the price trends of raw materials such as MB ethane, NYMEX natural gas, East China propane, Brent crude oil, domestic steam coal, and naphtha, and the profit situations of different production routes for polyethylene and polypropylene [24][27][29]. - **2.4 Coal - Chemical Sector**: The report presented the price trends and gross profit situations of coal - coke products, traditional coal - chemical products, and new materials in the coal - chemical industry [40][46][51]. - **2.5 Animal Nutrition Products Sector**: It showed the price trends of VA, VE, solid methionine, and liquid methionine [55][59][61].

Group 1 - The core point of the article is that Xinhecheng's perfluorohexyl octane product is currently being sold normally, primarily for use in the pharmaceutical sector [2] Group 2 - The product's application in the pharmaceutical field indicates a potential growth area for the company [2] - The announcement was made on an interactive platform, highlighting the company's engagement with stakeholders [2]

人民财讯1月16日电，新和成（002001）1月16日在互动平台表示，公司出口美国的销售收入占总营业收 入比重在10%以下。公司受伊朗关税影响很小。 ...

新和成（002001.SZ）1月16日在投资者互动平台表示，公司出口美国的销售收入占总营业收入比重在 10%以下。公司受伊朗关税影响很小。 每经AI快讯，有投资者在投资者互动平台提问：请问公司出口美国的比例是多少？受伊朗关税的影响 如何？谢谢！ （文章来源：每日经济新闻） ...

Group 1 - The core product of the company, perfluorohexyl octane, is an important raw material for drugs treating dry eye syndrome [2] - The company responded to an investor inquiry regarding the application of its product in innovative pharmaceuticals [2] - The interaction took place on an investor communication platform, indicating active engagement with stakeholders [2]

Core Viewpoint - The stock price of New Harmony has experienced fluctuations, with a recent decline of 2.02% and a total market capitalization of 77.33 billion yuan. The company has shown mixed performance in terms of stock price changes over different time frames [1]. Financial Performance - For the period from January to September 2025, New Harmony achieved a revenue of 16.642 billion yuan, representing a year-on-year growth of 5.45%. The net profit attributable to shareholders was 5.321 billion yuan, reflecting a significant increase of 33.37% compared to the previous year [2]. Shareholder Information - As of September 30, 2025, the number of shareholders for New Harmony increased to 82,500, up by 2.15%. The average circulating shares per person decreased by 2.11% to 36,823 shares [2]. - The company has distributed a total of 16.114 billion yuan in dividends since its A-share listing, with 5.682 billion yuan distributed over the past three years [3]. Major Shareholders - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 185 million shares, which is a decrease of 6.6675 million shares from the previous period. Other notable shareholders include various ETFs, all of which have seen a reduction in their holdings [3].

Core Viewpoint - New Hope's stock price has shown a positive trend with a year-to-date increase of 2.50% and a significant rise of 10.96% over the past 60 days, indicating strong market interest and performance [1]. Financial Performance - For the period from January to September 2025, New Hope achieved a revenue of 16.642 billion yuan, reflecting a year-on-year growth of 5.45%. The net profit attributable to shareholders reached 5.321 billion yuan, marking a substantial increase of 33.37% [2]. Shareholder Information - As of September 30, 2025, the number of shareholders for New Hope increased to 82,500, up by 2.15%. The average number of circulating shares per shareholder decreased by 2.11% to 36,823 shares [2]. - The company has distributed a total of 16.114 billion yuan in dividends since its A-share listing, with 5.682 billion yuan distributed over the past three years [3]. Major Shareholders - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 185 million shares, which is a decrease of 6.6675 million shares from the previous period. Other notable shareholders include Huatai-PB CSI 300 ETF and E Fund CSI 300 Medical ETF, both of which have also seen reductions in their holdings [3].

Core Insights - The report highlights that Xinhecheng (002001) is positioned to become a global leader in the fine chemical industry by leveraging high-barrier core intermediates and focusing on domestic substitution [2][12] - The nutritional products segment is expected to recover, with methionine likely to see both volume and price increases as the impact of BASF's incident fades [12] - The flavor and fragrance segment is experiencing steady growth, with the company leading in domestic scale and continuously expanding its product offerings [12] - The new materials segment demonstrates synergy between industry and technology, with the company planning to enhance its production capacity for key intermediates like adiponitrile [12] Nutritional Products Segment - The nutritional products segment is at a turning point, with methionine demand expected to grow at 6% globally, supported by a strong cost curve and reduced overseas competition due to environmental pressures [12] - The company has a significant cost advantage by mastering core intermediates and integrating the vitamin A and E supply chain [12] - The anticipated completion of projects for 70,000 tons of solid methionine and 180,000 tons of liquid methionine in 2025 is expected to lead to volume and price increases in 2026 [12] Flavor and Fragrance Segment - The global flavor and fragrance market is dominated by a few players, with high barriers to entry, and the company is well-positioned to benefit from this concentration [12] - The segment is expected to grow as downstream manufacturers are less sensitive to price changes and seek comprehensive service offerings [12] New Materials Segment - The new materials segment is characterized by high-barrier processes and significant domestic substitution potential, with the company being the second-largest producer of PPS globally [12] - The company is planning a nylon integration project in Tianjin, with an initial capacity of 100,000 tons per year for adiponitrile and hexamethylenediamine [12] Financial Projections - Revenue projections for the company are estimated at 23.183 billion, 23.426 billion, and 24.478 billion yuan for 2025, 2026, and 2027 respectively, with net profit forecasts of 6.733 billion, 7.202 billion, and 8.058 billion yuan [12] - The expected EPS for the same years is 2.19, 2.34, and 2.62 yuan per share, indicating a compound annual growth rate (CAGR) of 11% for net profit [12] - The company's PE ratio for 2026 is projected to be around 11 times, which is below the average PE of comparable companies at 15 times [12]

Core Viewpoint - The company Xinhecheng is positioned as a global leader in the fine chemical industry, leveraging high-barrier core intermediates and focusing on domestic substitution to drive growth [1] Group 1: Business Strategy - The company has successfully overcome challenges in the domestic production of Vitamin A and E, and is now extending its industrial chain through high-barrier core intermediates, customer collaboration, and domestic substitution [1] - The company has diversified into multiple sectors including nutrition products, flavor and fragrance, new materials, active pharmaceutical ingredients, and intermediates, as well as bio-fermentation [1] Group 2: Market Conditions - Current methionine prices are declining, but the cost curve remains steep with strong bottom support; the company is positioned at the leftmost side of this curve, ensuring solid bottom-line profits [1] - Overseas production capacity is gradually exiting due to cost and environmental pressures, with the EU carbon tariff in 2026 potentially accelerating this trend, leading to expected price elasticity for methionine [1] Group 3: Future Prospects - In 2025, the company plans to implement a 70,000-ton solid methionine technical upgrade and an 180,000-ton liquid methionine project, which may lead to simultaneous volume and profit growth in 2026 [1] - The flavor and fragrance segment continues to expand, showing steady growth, while new materials demonstrate industrial and technological synergy, with additional growth potential from adiponitrile [1] - Given the company's status as a global leader in fine chemicals, its significant scale cost advantages, and the cyclical bottom with elasticity and new material growth potential, a "buy" rating is maintained [1]

Investment Rating - The report maintains an "Overweight" rating for the company, indicating a positive outlook based on its growth potential and market position [6][7]. Core Insights - The company is positioned as a global leader in fine chemicals, focusing on domestic substitution and leveraging high-barrier core intermediates to drive growth across multiple segments, including nutrition, flavor and fragrance, new materials, and pharmaceuticals [4][18]. - The financial forecast shows significant revenue growth, with projected revenues of 231.83 billion, 234.26 billion, and 244.78 billion yuan for 2025, 2026, and 2027 respectively, alongside an upward revision of net profit estimates [5][7]. - The company benefits from a solid profit base, particularly in the methionine segment, which is expected to see volume and price increases due to market dynamics and new project launches [6][18]. Financial Data and Profit Forecast - Total revenue is projected to grow from 21,610 million yuan in 2024 to 24,478 million yuan in 2027, with a compound annual growth rate (CAGR) of 11% [5][7]. - The net profit attributable to shareholders is expected to rise from 5,869 million yuan in 2024 to 8,058 million yuan in 2027, reflecting a strong growth trajectory [5][7]. - Earnings per share (EPS) are forecasted to increase from 1.91 yuan in 2024 to 2.62 yuan in 2027, indicating robust profitability [5][7]. Business Segments and Growth Drivers - The nutrition segment, particularly vitamins A and E, is expected to stabilize, while methionine demand is projected to grow at over 6%, supported by a strong cost advantage [6][8]. - The flavor and fragrance segment is anticipated to continue its steady growth, driven by the company's leading position and ongoing product expansion [6][8]. - The new materials segment is set to benefit from the integration of nylon projects, which are expected to enhance the company's competitive edge in the market [6][8]. Market Position and Competitive Advantage - The company has established a strong market presence through its diversified product offerings and strategic focus on high-barrier intermediates, which provide a competitive edge in the fine chemicals industry [4][18]. - The report highlights the company's ability to maintain profitability even in challenging market conditions, thanks to its cost advantages and strategic project developments [6][18].